Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.400
+0.070 (3.00%)
At close: Apr 17, 2026, 4:00 PM EDT
2.381
-0.019 (-0.80%)
After-hours: Apr 17, 2026, 7:54 PM EDT
Palisade Bio Employees
Palisade Bio had 14 employees as of December 31, 2025. The number of employees increased by 6 or 75.00% compared to the previous year.
Employees
14
Change (1Y)
6
Growth (1Y)
75.00%
Revenue / Employee
n/a
Profits / Employee
-$1,198,643
Market Cap
401.81M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 6 | 75.00% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | -3 | -25.00% |
| Dec 31, 2022 | 12 | -1 | -7.69% |
| Dec 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cabaletta Bio | 156 |
| Nautilus Biotechnology | 130 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 96 |
| Armata Pharmaceuticals | 60 |
| X4 Pharmaceuticals | 45 |
| Avalo Therapeutics | 33 |
PALI News
- 2 days ago - Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 - GlobeNewsWire
- 10 days ago - Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference - GlobeNewsWire
- 19 days ago - Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn's Disease - GlobeNewsWire
- 6 weeks ago - Palisade Bio Announces Participation in Two Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026 - GlobeNewsWire
- 2 months ago - Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board - GlobeNewsWire
- 2 months ago - Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium - GlobeNewsWire
- 2 months ago - Palisade Bio to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire